August 13, 2026

Medical Oddities: Not a feces sign, a wine cork

Imaging twists, intimacy rules, kombucha, and stress biology keep science delightfully odd.

MDSpire News

July 29, 2026

Medical Oddities: Tattoo Regret Meets Nanotech

This week is about smart tattoos, social clues, pool perks, and tea's surprising brain connection.

MDSpire News

July 07, 2026

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

MDSpire News

July 01, 2026

Medical Oddities: Do Jellyfish Hold a Healing Secret?

Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

MDSpire News

June 25, 2026

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

MDSpire News

June 19, 2026

First HIV-Positive-to-HIV-Positive Lung Transplant Reported

The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.

MDSpire News

June 11, 2026

Urologic Surgeon Sworn in as AMA President

He brings more than 25 years of urologic surgery experience to the role, including 15 years specializing in robotic urologic oncology procedures. As only the second urologist and third Black physician...

The ASCO Post

June 03, 2026

Hospital AI Fails to Flag Drug Diversion

"I've never myself seen these technologies be called out in that specific way"

Kff Health News

June 01, 2026

Many Patients With Limited Sentinel Node–Positive Breast Cancer Can Safely Avoid Axillary Dissection, Study Shows

Updated results from the phase III SENOMAC trial suggest that many patients with early-stage breast cancer and limited spread to sentinel lymph nodes can safely forgo axillary lymph node dissection, a...

The ASCO Post

June 01, 2026

Many Patients With Limited Sentinel Node–Positive Breast Cancer Can Safely Avoid Axillary Dissection, Study Shows

Updated results from the phase III SENOMAC trial suggest that many patients with early-stage breast cancer and limited spread to sentinel lymph nodes can safely forgo axillary lymph node dissection, a...

The ASCO Post